228 related articles for article (PubMed ID: 20132413)
21. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
Laury AR; Hornick JL; Perets R; Krane JF; Corson J; Drapkin R; Hirsch MS
Am J Surg Pathol; 2010 May; 34(5):627-35. PubMed ID: 20414098
[TBL] [Abstract][Full Text] [Related]
22. AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
Stavnes HT; Nymoen DA; Langerød A; Holth A; Børresen Dale AL; Davidson B
Virchows Arch; 2013 Feb; 462(2):163-73. PubMed ID: 23242172
[TBL] [Abstract][Full Text] [Related]
23. Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival.
Brenne K; Nymoen DA; Hetland TE; Trope' CG; Davidson B
Hum Pathol; 2012 Apr; 43(4):496-505. PubMed ID: 21855111
[TBL] [Abstract][Full Text] [Related]
24. Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.
Qiu C; Wang Y; Wang X; Zhang Q; Li Y; Xu Y; Jin C; Bu H; Zheng W; Yang X; Lu N; Kong B
Int J Oncol; 2018 Jun; 52(6):2041-2050. PubMed ID: 29620196
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.
Jazaeri AA; Yee CJ; Sotiriou C; Brantley KR; Boyd J; Liu ET
J Natl Cancer Inst; 2002 Jul; 94(13):990-1000. PubMed ID: 12096084
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
Madore J; Ren F; Filali-Mouhim A; Sanchez L; Köbel M; Tonin PN; Huntsman D; Provencher DM; Mes-Masson AM
J Pathol; 2010 Feb; 220(3):392-400. PubMed ID: 19967725
[TBL] [Abstract][Full Text] [Related]
27. Targeted Genomic Sequencing Reveals Novel
Jung YY; Woo HY; Kim HS
Anticancer Res; 2019 Jun; 39(6):2883-2889. PubMed ID: 31177126
[TBL] [Abstract][Full Text] [Related]
28. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor gene, cell surface adhesion molecule, and multidrug resistance in Müllerian serous carcinomas: clinical divergence without immunophenotypic differences.
Soslow RA; Slomovitz BM; Saqi A; Baergen RN; Caputo TA
Gynecol Oncol; 2000 Dec; 79(3):430-7. PubMed ID: 11104615
[TBL] [Abstract][Full Text] [Related]
30. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Bonome T; Lee JY; Park DC; Radonovich M; Pise-Masison C; Brady J; Gardner GJ; Hao K; Wong WH; Barrett JC; Lu KH; Sood AK; Gershenson DM; Mok SC; Birrer MJ
Cancer Res; 2005 Nov; 65(22):10602-12. PubMed ID: 16288054
[TBL] [Abstract][Full Text] [Related]
31. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
Davidson B; Baekelandt M; Shih IeM
Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
[TBL] [Abstract][Full Text] [Related]
32. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer.
Sawiris GP; Sherman-Baust CA; Becker KG; Cheadle C; Teichberg D; Morin PJ
Cancer Res; 2002 May; 62(10):2923-8. PubMed ID: 12019173
[TBL] [Abstract][Full Text] [Related]
33. Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma.
Flavin RJ; Smyth PC; Laios A; O'Toole SA; Barrett C; Finn SP; Russell S; Ring M; Denning KM; Li J; Aherne ST; Sammarae DA; Aziz NA; Alhadi A; Sheppard BL; Lao K; Sheils OM; O'Leary JJ
Mod Pathol; 2009 Feb; 22(2):197-205. PubMed ID: 18677302
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes.
Bignotti E; Tassi RA; Calza S; Ravaggi A; Bandiera E; Rossi E; Donzelli C; Pasinetti B; Pecorelli S; Santin AD
Am J Obstet Gynecol; 2007 Mar; 196(3):245.e1-11. PubMed ID: 17346539
[TBL] [Abstract][Full Text] [Related]
35. Kindlin-2 inhibits serous epithelial ovarian cancer peritoneal dissemination and predicts patient outcomes.
Ren C; Du J; Xi C; Yu Y; Hu A; Zhan J; Guo H; Fang W; Liu C; Zhang H
Biochem Biophys Res Commun; 2014 Mar; 446(1):187-94. PubMed ID: 24583125
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profiles in three histologic types, clear-cell, endometrioid and serous ovarian carcinomas.
Pamuła-Piłat J; Rubel T; Rzepecka IK; Olbryt M; Herok R; Dansonka-Mieszkowska A; Grzybowska E; Kupryjańczyk J
J Biol Regul Homeost Agents; 2014; 28(4):659-74. PubMed ID: 25620176
[TBL] [Abstract][Full Text] [Related]
37. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening.
Karlan BY; Baldwin RL; Lopez-Luevanos E; Raffel LJ; Barbuto D; Narod S; Platt LD
Am J Obstet Gynecol; 1999 Apr; 180(4):917-28. PubMed ID: 10203660
[TBL] [Abstract][Full Text] [Related]
38. The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma.
Davidson B; Risberg B; Berner A; Bedrossian CW; Reich R
Semin Diagn Pathol; 2006 Feb; 23(1):35-43. PubMed ID: 17044194
[TBL] [Abstract][Full Text] [Related]
39. Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect.
Burdennyy AM; Filippova EA; Ivanova NA; Lukina SS; Pronina IV; Loginov VI; Fridman MV; Kazubskaya TP; Utkin DO; Braga EA; Kushlinskii NE
Bull Exp Biol Med; 2021 Jul; 171(3):370-374. PubMed ID: 34292442
[TBL] [Abstract][Full Text] [Related]
40. Gene expression patterns that characterize advanced stage serous ovarian cancers.
Lancaster JM; Dressman HK; Whitaker RS; Havrilesky L; Gray J; Marks JR; Nevins JR; Berchuck A
J Soc Gynecol Investig; 2004 Jan; 11(1):51-9. PubMed ID: 14706684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]